Results we're proud to share
We believe in honest, transparent reporting. Here's a clear look at our outcomes — no spin, no fine print.
positive pregnancy test per embryo transfer — the same metric IVF chains advertise
take-home baby per embryo transfer — the harder number we also publish
born through our ART programme
established August 1998
Two clearly-defined figures, honestly explained
Transparency means defining exactly what we measure — both the metric the chains headline and the harder one most of them don't publish.
90.6% — beta-hCG positive rate. The share of embryo transfers at our Solapur centre that result in a positive beta-hCG (pregnancy) blood test. This is the same metric that large national IVF chains advertise as their “success rate,” so it's a like-for-like comparison.
~72% — live-birth (take-home baby) rate. The share of transfers that go on to the birth of a baby — the hardest and most meaningful endpoint, which most IVF chains do not publish. We do.
The two sit on the same journey: a positive pregnancy test comes first (90.6%), and a smaller share carry through to a live birth (~72%). A live-birth rate can never be higher than the pregnancy-test rate — so publishing both, side by side, is the most honest picture we can give. Your individual odds depend on age and diagnosis, and your specialist will give you a realistic, personal estimate at consultation.
Higher on the metric they advertise — and on the one they don't
National IVF chains headline a beta-hCG / pregnancy-test rate. Measured the same way, here's how Shobha IVF compares.
| Centre | Advertised beta-hCG / “success” rate | Live-birth rate published? |
|---|---|---|
| Shobha IVF | 90.6% | Yes — ~72% per transfer |
| National IVF chains | ~71–74% (advertised) | Typically not published |
For context, live-birth rates at leading ART centres are commonly reported in the 55–65% per-transfer range — so our ~72% sits above the typical benchmark. Our programme is led by Dr. Milind B. Patil (MD, DNB, MNAMS) using a routine freeze-all, blastocyst-culture protocol with PGT availability.
Comparison figures are national IVF chains' own publicly advertised numbers and may be measured differently; we show them only to clarify which metric is being compared.
Every cycle, every month — openly published
Rather than a single headline number, here is our clinic's own cycle register: 2,262 embryo transfers over three financial years, month by month, from positive pregnancy test through to live birth.
| Month | ET | Beta-hCG | Clinical | Live birth |
|---|---|---|---|---|
| Apr 2025 | 65 | 93.8% | 89.2% | 80.0% |
| May 2025 | 73 | 93.2% | 91.8% | 75.3% |
| Jun 2025 | 81 | 88.9% | 87.7% | 72.8% |
| Jul 2025 | 75 | 88.0% | 85.3% | 69.3% |
| Aug 2025 | 78 | 97.4% | 96.2% | in progress |
| Sep 2025 | 81 | 93.8% | 92.6% | in progress |
| Oct 2025 | 63 | 93.7% | 93.7% | in progress |
| Nov 2025 | 71 | 95.8% | 94.4% | in progress |
| Dec 2025 | 64 | 87.5% | 87.5% | in progress |
| Jan 2026 | 78 | 92.3% | 73.1% | in progress |
| Feb 2026 | 64 | 92.2% | 90.6% | in progress |
| Mar 2026 | 73 | 90.4% | 80.8% | in progress |
| Year total | 866 | 92.3% | 88.5% | 74.1% |
“In progress” marks recent transfers whose pregnancies are ongoing — a live birth follows a transfer by about nine months, so those deliveries have not completed yet. The year's live-birth rate (74.1%) is calculated only over the 294 transfers whose outcomes are final, so it is never inflated by counting pending cycles as failures.
How we measure what matters
We report outcomes the way patients actually experience them — clearly and in context.
Defined metrics, not vague claims
Both figures are defined per embryo transfer at our Solapur centre: a 90.6% beta-hCG positive (pregnancy-test) rate and a ~72% live-birth rate. You know exactly what each one measures.
We publish live birth, not just pregnancy
A positive test is the first milestone, not a guarantee of a baby. Most chains stop at the pregnancy-test rate; we also publish the harder live-birth number so the two are never blurred.
Honest, in context
Our beta-hCG rate is shown on the same basis the chains advertise, and our live-birth rate is benchmarked against published ranges. We discuss your personal odds candidly at consultation — never inflated, never one-size-fits-all.
The information on this page is general and educational, and is not a substitute for professional medical advice, diagnosis or treatment. Fertility outcomes vary from person to person and depend on age, diagnosis and other individual factors; no result is guaranteed. Figures shown are measured per embryo transfer at our Solapur centre — a beta-hCG positive (pregnancy-test) rate and a live-birth rate; a positive test is an earlier milestone than a live birth, and any comparison figures for other centres are their own publicly advertised numbers, which may be measured differently. Please consult our specialists for advice specific to you.
Want to understand your personal odds?
Book a consultation for an honest, individualised assessment based on your unique situation.
Book a Consultation